Ozempic, known generically as semaglutide, is part of the GLP-1 drug class used for type 2 diabetes treatment, blood sugar control, and, in many cases, weight loss
Based on trial enrollment criteria, candidates typically had a BMI over 30 or a BMI of 27+ with weight-related health conditions like high cholesterol or high blood pressure
listings carry research-only labeling, usage restrictions, and batch-level documentation to support responsible, non-clinical work
Retatrutide is not a controlled substance under UK law
*This is intended to provide general information, not legal advice
Skip if: you want the absolute lowest sticker or video visits